7-Methoxy-2-tetralone, 97.0%, 25g

5-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 1g

3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine, 97%, 250mg

Triisopropoxy(methyl)titanium, 1M in THF, 1.0 M in THF, 10g

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 250mg

2-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine>98.0%(GC)(T)5g

2,6-Dimethylbenzo[d]thiazole, 95.0%, 5g

2-Methyl-2-propylpropane-1,3-diol, 95.0%, 500g

1,2-Tetradecanediol>90.0%(GC)25g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-chlorophenyl)propanoic acid, 95.0%, 100mg

6-Mercaptopurine Monohydrate>98.0%(HPLC)(T)1g

1-Ethyl-5-nitro-1H-indazole, 95.0%, 100mg

N-Hydroxymethylphthalimide>98.0%(HPLC)(N)250g